Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T01:57:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Content expanded with new immunology terms and an upgraded revision (v3.1.0), plus fresh date stamps; older revision and generic date stamps removed. Overall, the page now includes more comprehensive and up-to-date terminology.
    Difference
    2%
    Check dated 2025-09-28T23:29:05.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed; no other substantive changes to core content, pricing, or time-slot information are present.
    Difference
    0.2%
    Check dated 2025-09-14T09:48:53.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T07:36:59.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed medical terms related to leukemia and various compounds, while removing several location-related terms and some medical classifications.
    Difference
    4%
    Check dated 2025-08-31T00:59:56.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.11 to v2.16.12 and has removed older dates from May and June 2025, replacing them with new dates in August 2025.
    Difference
    0.6%
    Check dated 2025-08-16T19:07:07.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.